Del Frisco’s Restaurant Group, Inc. Reports Third Quarter 2018 Results
Updates Fiscal Year 2018 Guidance IRVING, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) — Del Frisco’s Restaurant Group, Inc. (“Del Frisco’s”) […]
Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
– Checkpoint combination studies support progression into registration pathway for metastatic breast cancer and potential expansion of indications – – […]
ContraFect Appoints Michael Messinger as Chief Financial Officer
YONKERS, N.Y., Nov. 12, 2018 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial
Focus will be on Milestones for Development and Commercialization CAP-1002 Therapy for Duchenne Muscular Dystrophy LOS ANGELES, Nov. 12, 2018 […]
DynaEnergetics and GEODynamics Reach Settlement Agreement
HOUSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) — DynaEnergetics, a business of DMC Global Inc. (Nasdaq: BOOM), today announced it has […]
Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness […]
Amicus Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference
CRANBURY, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and […]
Mersana Scientists Present Updates on XMT-1522, XMT-1536 and the Dolaflexin Platform at World ADC 2018
Mersana Chief Scientific Officer, Timothy B. Lowinger, Ph.D. to chair 2018 Conference CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) — […]
Retrophin Announces U.S. FDA Acceptance of NDA Filing for the New Formulation of Thiola® (tiopronin) in the Treatment of Cystinuria
PDUFA date set for June 30, 2019 SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today […]
Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018
Total Revenues for First Nine Months of 2018 were $66.3 Million, a 1% Decrease Year-Over-Year Gross Profit for First Nine […]
